Global Prostate Cancer Medicine Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Prostate Cancer Medicine Revenue
• 1.4 Market by Type
  • 1.4.1 Global Prostate Cancer Medicine Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 LHRH Antagonists
  • 1.4.3 LHRH Analogs
  • 1.4.4 Antiandrogens
  • 1.4.5 Pipeline Drugs for Hormonal Therapy
• 1.5 Market by Application
  • 1.5.1 Global Prostate Cancer Medicine Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Prostate Cancer Medicine Market Perspective (2015-2026)
• 2.2 Global Prostate Cancer Medicine Growth Trends by Regions
  • 2.2.1 Prostate Cancer Medicine Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Prostate Cancer Medicine Historic Market Share by Regions (2015-2020)
  • 2.2.3 Prostate Cancer Medicine Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Prostate Cancer Medicine Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Prostate Cancer Medicine Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Prostate Cancer Medicine Players by Market Size
  • 3.1.1 Global Top Prostate Cancer Medicine Players by Revenue (2015-2020)
  • 3.1.2 Global Prostate Cancer Medicine Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Prostate Cancer Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Prostate Cancer Medicine Market Concentration Ratio
  • 3.2.1 Global Prostate Cancer Medicine Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Prostate Cancer Medicine Revenue in 2019
• 3.3 Prostate Cancer Medicine Key Players Head office and Area Served
• 3.4 Key Players Prostate Cancer Medicine Product Solution and Service
• 3.5 Date of Enter into Prostate Cancer Medicine Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Prostate Cancer Medicine Historic Market Size by Type (2015-2020)
• 4.2 Global Prostate Cancer Medicine Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Prostate Cancer Medicine Market Size by Application (2015-2020)
• 5.2 Global Prostate Cancer Medicine Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Prostate Cancer Medicine Market Size (2015-2020)
• 6.2 Prostate Cancer Medicine Key Players in North America (2019-2020)
• 6.3 North America Prostate Cancer Medicine Market Size by Type (2015-2020)
• 6.4 North America Prostate Cancer Medicine Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Prostate Cancer Medicine Market Size (2015-2020)
• 7.2 Prostate Cancer Medicine Key Players in Europe (2019-2020)
• 7.3 Europe Prostate Cancer Medicine Market Size by Type (2015-2020)
• 7.4 Europe Prostate Cancer Medicine Market Size by Application (2015-2020)

8 China

• 8.1 China Prostate Cancer Medicine Market Size (2015-2020)
• 8.2 Prostate Cancer Medicine Key Players in China (2019-2020)
• 8.3 China Prostate Cancer Medicine Market Size by Type (2015-2020)
• 8.4 China Prostate Cancer Medicine Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Prostate Cancer Medicine Market Size (2015-2020)
• 9.2 Prostate Cancer Medicine Key Players in Japan (2019-2020)
• 9.3 Japan Prostate Cancer Medicine Market Size by Type (2015-2020)
• 9.4 Japan Prostate Cancer Medicine Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Prostate Cancer Medicine Market Size (2015-2020)
• 10.2 Prostate Cancer Medicine Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Prostate Cancer Medicine Market Size by Type (2015-2020)
• 10.4 Southeast Asia Prostate Cancer Medicine Market Size by Application (2015-2020)

11 India

• 11.1 India Prostate Cancer Medicine Market Size (2015-2020)
• 11.2 Prostate Cancer Medicine Key Players in India (2019-2020)
• 11.3 India Prostate Cancer Medicine Market Size by Type (2015-2020)
• 11.4 India Prostate Cancer Medicine Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Prostate Cancer Medicine Market Size (2015-2020)
• 12.2 Prostate Cancer Medicine Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Prostate Cancer Medicine Market Size by Type (2015-2020)
• 12.4 Central & South America Prostate Cancer Medicine Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 AstraZeneca plc
  • 13.1.1 AstraZeneca plc Company Details
  • 13.1.2 AstraZeneca plc Business Overview
  • 13.1.3 AstraZeneca plc Prostate Cancer Medicine Introduction
  • 13.1.4 AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2015-2020))
  • 13.1.5 AstraZeneca plc Recent Development
• 13.2 Active Biotech
  • 13.2.1 Active Biotech Company Details
  • 13.2.2 Active Biotech Business Overview
  • 13.2.3 Active Biotech Prostate Cancer Medicine Introduction
  • 13.2.4 Active Biotech Revenue in Prostate Cancer Medicine Business (2015-2020)
  • 13.2.5 Active Biotech Recent Development
• 13.3 Bristol Myers-Squibb
  • 13.3.1 Bristol Myers-Squibb Company Details
  • 13.3.2 Bristol Myers-Squibb Business Overview
  • 13.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Introduction
  • 13.3.4 Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2015-2020)
  • 13.3.5 Bristol Myers-Squibb Recent Development
• 13.4 Teva Pharmaceuticals Industries Ltd.
  • 13.4.1 Teva Pharmaceuticals Industries Ltd. Company Details
  • 13.4.2 Teva Pharmaceuticals Industries Ltd. Business Overview
  • 13.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Introduction
  • 13.4.4 Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2015-2020)
  • 13.4.5 Teva Pharmaceuticals Industries Ltd. Recent Development
• 13.5 Johnson & Johnson
  • 13.5.1 Johnson & Johnson Company Details
  • 13.5.2 Johnson & Johnson Business Overview
  • 13.5.3 Johnson & Johnson Prostate Cancer Medicine Introduction
  • 13.5.4 Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2015-2020)
  • 13.5.5 Johnson & Johnson Recent Development
• 13.6 Pfizer Inc.
  • 13.6.1 Pfizer Inc. Company Details
  • 13.6.2 Pfizer Inc. Business Overview
  • 13.6.3 Pfizer Inc. Prostate Cancer Medicine Introduction
  • 13.6.4 Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2015-2020)
  • 13.6.5 Pfizer Inc. Recent Development
• 13.7 Bayer AG
  • 13.7.1 Bayer AG Company Details
  • 13.7.2 Bayer AG Business Overview
  • 13.7.3 Bayer AG Prostate Cancer Medicine Introduction
  • 13.7.4 Bayer AG Revenue in Prostate Cancer Medicine Business (2015-2020)
  • 13.7.5 Bayer AG Recent Development
• 13.8 Abbott Laboratories
  • 13.8.1 Abbott Laboratories Company Details
  • 13.8.2 Abbott Laboratories Business Overview
  • 13.8.3 Abbott Laboratories Prostate Cancer Medicine Introduction
  • 13.8.4 Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2015-2020)
  • 13.8.5 Abbott Laboratories Recent Development
• 13.9 Astellas Pharma Inc.
  • 13.9.1 Astellas Pharma Inc. Company Details
  • 13.9.2 Astellas Pharma Inc. Business Overview
  • 13.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Introduction
  • 13.9.4 Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2015-2020)
  • 13.9.5 Astellas Pharma Inc. Recent Development
• 13.10 Roche Holding AG
  • 13.10.1 Roche Holding AG Company Details
  • 13.10.2 Roche Holding AG Business Overview
  • 13.10.3 Roche Holding AG Prostate Cancer Medicine Introduction
  • 13.10.4 Roche Holding AG Revenue in Prostate Cancer Medicine Business (2015-2020)
  • 13.10.5 Roche Holding AG Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer